Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PIEX 2
- Development stage
- Unknown
- Lead developer
- Becanex
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation, Oral, Sublingual
01
Overview
PIEX 2 (also known as Becanex PIEX 2) is a plant-identical, full-spectrum cannabis raw extract developed and manufactured by Becanex. Standardized to contain approximately 70% tetrahydrocannabinol (THC) and less than 1% cannabidiol (CBD), the extract is derived from the Strawberry OG cannabis strain (an Indica-dominant cultivar) using a gentle one-step extraction process that preserves the natural cannabinoid and terpene profile (including beta-caryophyllene, nerolidol, alpha-humulen, guaiol, and alpha-bisabolol). It is a prescription-only medical cannabis product in Germany, designed for compounding by pharmacists into various dosage forms such as oral or sublingual oil solutions, vaporizable inhalation extracts, capsules, suppositories, or topical preparations.
- Brand names
- Becanex PIEX 2PIEX 2PIEX2PIEX-2
- Other names
- 70% THC concentrateBecanex PIEX 2 70% THC RohextraktStrawberry OG strain extract
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on PIEX 2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PIEX 2.